


The objective of the fund is to provide a total return of capital and income in excess of the total return.
| Name | % Net Assets |
|---|---|
| Egdon Resources | 4.2% |
| CML Microsystems | 3.4% |
| Abcam | 2.6% |
| Brady | 2.6% |
| City Of London Investment Group | 2.5% |
| Staffline Group | 1.9% |
| Volex Group | 1.9% |
| Richoux Group | 1.9% |
| Research Now | 1.8% |
| Alliance Pharma | 1.7% |
| Key | % Net Assets |
|---|---|
| 4.2% | |
| 3.4% | |
| 2.6% | |
| 2.6% | |
| 87.2% |
| Date | 20-Aug-2025 |
|---|---|
| Bid | 779.17p |
| Offer | 779.17p |
| Currency | GBP |
| Change | -5.36p |
| % | -0.68% |
| YTD change | 17.12p |
| YTD % | 2.25% |
| Fund Inception | 04/10/2004 |
|---|---|
| Fund Manager | Giles Hargreave |
| TER | 1.53 (31-Jul-2012) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £500 |
| Savings | £100 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.19 |
You are here: research